The ZyCoV-D vaccine heralds a wave of DNA vaccines for various diseases that are undergoing clinical trials around the world.
GOLDEN, Colo. — September 14, 2021 - PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its partner, Scancell, has selected its devices to administer its two SARS-CoV-2 DNA vaccine candidates, SCOV1 and SCOV2. The vaccines will be exclusively administered using the PharmaJet Tropis® and PharmaJet Stratis® Needle-free Injection Systems.
We take a look at some of the COVID-19 vaccine candidates moving through clinical trials.
On Friday, the Indian government authorized a needle-free Covid-19 vaccine developed by an indigenous pharmaceutical company.
New Delhi: A decision on the approval of Zydus Cadila’s COVID-19 vaccine Zydus Cov-D is expected soon…
Zydus Cadila plans to roll out COVID vaccine 45-60 days after EUA nod; key points on needle-free, plasmid DNA shot
ZyCov-D when approved will help not only adults but also adolescents in the 12 to 18 years age group